Activation of dopamine receptor D2 to inhibit non-small cell lung cancer growth in vivo.

被引：0
|
作者：
Wu, Xiaoyuan [1 ]
Zhang, Chenxi [1 ]
Zhao, Wei [1 ]
机构：
[1] Southeast Univ, Nanjiing Chest Hosp, Sch Med, Cent Lab, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e23197
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23197
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pazopanib diminishes non-small cell lung cancer (NSCLC) growth and metastases in vivo
    Zhao, Honglin
    Yang, Fan
    Shen, Wang
    Wang, Yuli
    Li, Xuebing
    You, Jiacong
    Zhou, Qinghua
    [J]. THORACIC CANCER, 2015, 6 (02) : 133 - 140
  • [22] Novel SINE CRM1 antagonists for non-small cell lung cancer (NSCLC) in vitro and in vivo.
    Han, Xiaohong
    Wang, Shuai
    Shi, Yuankai
    Wang, Michael
    Zhang, Liang
    Fang, Bingliang
    McCauley, Dilara
    Kauffman, Michael
    Shacham, Sharon
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [23] Epidermal growth factor receptor mutations in patients with non-small cell lung cancer
    Johnson, BE
    Jänne, PA
    [J]. CANCER RESEARCH, 2005, 65 (17) : 7525 - 7529
  • [24] EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN TREATMENT OF NON-SMALL CELL LUNG CANCER
    Kilickap, Saadettin
    [J]. NOBEL MEDICUS, 2018, 14 (03): : 5 - 8
  • [25] The role of aromatase and epidermal growth factor receptor in non-small cell lung cancer
    Kritikou, I.
    Giannopoulou, E.
    Koutras, A.
    Dimitropoulos, K.
    Kalofonos, H.
    [J]. EJC SUPPLEMENTS, 2010, 8 (05): : 135 - 135
  • [26] Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
    Van Der Steen, Nele
    Giovannetti, Elisa
    Carbone, Daniela
    Leonetti, Alessandro
    Rolfo, Christian D.
    Peters, Godefridus J.
    [J]. CANCER DRUG RESISTANCE, 2018, 1 (04) : 230 - 249
  • [27] Update on epidermal growth factor receptor mutations in non-small cell lung cancer
    Riely, Gregory J.
    Politi, Katerina A.
    Miller, Vincent A.
    Pao, William
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (24) : 7232 - 7241
  • [28] Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer
    Lourdes, Laura S.
    Jalal, Shadia I.
    Hanna, Nasser
    [J]. ONCOLOGIST, 2015, 20 (09): : 975 - 978
  • [29] D2 dopamine receptor-mediated antiproliferation in a small cell lung cancer cell line, NCI-H69
    Senogles, Susan E.
    [J]. ANTI-CANCER DRUGS, 2007, 18 (07) : 801 - 807
  • [30] Activation of D2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells
    Roy, Soumyabrata
    Lu, Kai
    Nayak, Mukti Kant
    Bhuniya, Avishek
    Ghosh, Tithi
    Kundu, Suman
    Ghosh, Sarbari
    Baral, Rathindranath
    Dasgupta, Partha Sarathi
    Basu, Sujit
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (02) : 435 - 445
12345